BSYI

BioSyntech OTCPK:BSYI Stock Report

Last Price

US$0.000001

Market Cap

US$116.0

7D

0%

1Y

n/a

Updated

07 Nov, 2023

Data

Company Financials

BSYI Stock Overview

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery.

BSYI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

BioSyntech, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioSyntech
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.000001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.96%
5 Year Change-99.97%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

BSYIUS BiotechsUS Market
7D0%0.08%1.9%
1Yn/a11.6%31.1%

Return vs Industry: Insufficient data to determine how BSYI performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how BSYI performed against the US Market.

Price Volatility

Is BSYI's price volatile compared to industry and market?
BSYI volatility
BSYI Average Weekly Movementn/a
Biotechs Industry Average Movement11.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: BSYI has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BSYI's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994n/an/a

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company’s products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials.

BioSyntech, Inc. Fundamentals Summary

How do BioSyntech's earnings and revenue compare to its market cap?
BSYI fundamental statistics
Market capUS$116.00
Earnings (TTM)-US$9.29m
Revenue (TTM)US$145.80k

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BSYI income statement (TTM)
RevenueCA$199.70k
Cost of RevenueCA$69.36k
Gross ProfitCA$130.34k
Other ExpensesCA$12.85m
Earnings-CA$12.72m

Last Reported Earnings

Dec 31, 2009

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did BSYI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.